Trukera Medical is a U.S.–based ophthalmic medical diagnostic company that was previously known as TearLab and rebranded to Trukera in 2022 as it expanded its focus within corneal health. Trukera Medical was acquired by Bausch + Lomb through an affiliate from its private equity owner. Its core product is the ScoutPro® Osmolarity System, a point-of-care portable device that quantitatively measures tear osmolarity — the salt concentration in tears — which is an important biomarker for diagnosing dry eye disease and ocular surface disease.